Multi-Drug Featurization and Deep Learning Improve Patient-Specific Predictions of Adverse Events

por Anastopoulos, Ioannis N., Herczeg, Chloe K., Davis, Kasey N., Dixit, Atray C.
Publicado 2021

Correction: Anastopoulos et al. Multi-Drug Featurization and Deep Learning Improve Patient-Specific Predictions of Adverse Events. Int. J. Environ. Res. Public Health 2021, 18, 260...

por Anastopoulos, Ioannis N., Herczeg, Chloe K., Davis, Kasey N., Dixit, Atray C.
Publicado 2022

CODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing

por Jiang, Yuchao, Wang, Rujin, Urrutia, Eugene, Anastopoulos, Ioannis N., Nathanson, Katherine L., Zhang, Nancy R.
Publicado 2018

Using Transcriptional Signatures to Find Cancer Drivers with LURE

por Haan, David, Tao, Ruikang, Friedl, Verena, Anastopoulos, Ioannis N, Wong, Christopher K, Weinstein, Alana S, Stuart, Joshua M
Publicado 2020

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

por Shaffer, Sydney M., Dunagin, Margaret C., Torborg, Stefan R., Torre, Eduardo A., Emert, Benjamin, Krepler, Clemens, Beqiri, Marilda, Sproesser, Katrin, Brafford, Patricia A., Xiao, Min, Eggan, Elliott, Anastopoulos, Ioannis N., Vargas-Garcia, Cesar A., Singh, Abhyudai, Nathanson, Katherine L., Herlyn, Meenhard, Raj, Arjun
Publicado 2017

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

por Maxwell, Kara N., Wubbenhorst, Bradley, Wenz, Brandon M., De Sloover, Daniel, Pluta, John, Emery, Lyndsey, Barrett, Amanda, Kraya, Adam A., Anastopoulos, Ioannis N., Yu, Shun, Jiang, Yuchao, Chen, Hao, Zhang, Nancy R., Hackman, Nicole, D’Andrea, Kurt, Daber, Robert, Morrissette, Jennifer J. D., Mitra, Nandita, Feldman, Michael, Domchek, Susan M., Nathanson, Katherine L.
Publicado 2017